Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4634_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
12 Мб
Скачать
☆
40
https://t.me/medicina_free
4 Blue Laser Therapy ofExudative Lesions oftheVocal Folds
4.3 Blue Laser Therapy ofVocal Fold Cysts
4.3.1 Introduction
Vocal fold cysts are sac-like lesions of the vocal folds located in the supercial layer of the lamina propria. These are categorized as epidermoid cysts or mucus retention cysts. Epidermoid cysts can be either congenital or post-traumatic. Congenital epidermoid cysts develop from subepithelial cell rests derived from the fourth and sixth branchial arches, whereas traumatic vocal fold cysts result from involution or ingrowth of keratin into the supercial layer of the lamina propria [2, 3, 11]. Mucoid cysts arise secondary to occlusion of ducts of mucus glands and are encountered most often on the inferior surface or free edge of the vocal fold. Vocal fold cysts are more common in females and may occur at any age. The size of the cyst has been linked to uctuations in sex hormones with worsening of voice symptoms toward the end of the menstrual cycle [55].
Patients with vocal fold cysts usually present with dysphonia that is gradual in onset and associ­ated with voice fatigue. History of phonotrauma such as voice abuse, cough, or repetitive throat clearing may be present. Other symptoms com­monly reported by professional voice users include decrease in voice efciency, inability to sustain a note, loss of high notes, and difculty in transition between voice registers. In a study on seven sing­ers (four females and three males) with vocal fold masses, Echternach etal. reported irregularities in the passaggio that improved following therapy [56]. On perceptual evaluation, the voice is described as rough and at times breathy. Large cyst may cause diplophonia as described above in the section on vocal fold polyps. The perceptual voice changes are accompanied by an increase in the perturbation parameters, shimmer, and jitter and increases in noise-to- harmonic ratio and voice tur­bulence index [57]. On laryngeal examination, cysts of the vocal fold can be unilateral or bilateral. They are often misdiagnosed as nodules especially when there is a reactive lesion on the contralateral vocal fold. Laryngeal videostroboscopic examina­tion shows asymmetry, often with impairment or
reduction of mucosal waves at the site of the lesion. Typically, uid can be seen within the lesion. Scar and indentation may be present at the base of the lesion and in the reactive lesion at the contact point on the contralateral vocal fold. Although the lesion is usually limited to the super­cial layer of the lamina propria, it may also adhere to the mucosal cover and/or vocal ligament resulting in decrease or absence of mucosal waves. Common causes for the adherence of the cyst to the deep structures of the vocal fold include bleed­ing and inammation around the wall of the cyst associated with repeated phonotrauma which ulti­mately led to scar formation [58]. In a study on the videostroboscopic ndings in subjects with vari­ous lesions of the vocal folds, Shohet etal. reported a decrease or absence of mucosal waves in all patients with vocal fold cysts [59]. The authors stressed the added value of laryngeal videostrobo­scopic examination in differentiating vocal fold cysts from other lesions of the vocal folds. In cases with no scar with normal malleability of the vocal fold cover, the cyst can show an “egg in a soup” sign during phonation [2]. A better way to visual­ize the cyst in some cases is to ask the patient to sing moderately a high note. This phonatory task elongates the vocal fold and thins the vocal fold cover, thus allowing better appreciation of the nature and boundaries of the cyst. However, some cysts are more obvious elsewhere in the voice range, and strobovideolaryngoscopy should be performed at various frequencies and intensities. Incomplete closure of the vocal folds also may be observed in case of large cyst, or with a cyst (s) located on the free edge of the vocal fold.
Treatment of vocal fold cysts is multidisci­plinary. Surgical excision usually is required to optimize voice although voice therapy should be initiated pre-operatively to address the compensa­tory hyperfunctional laryngeal behavior and teach vocal hygiene. Reactive lesions often improve through voice therapy, and inammation of the cyst also may improve revealing that the lesion is smaller than thought initially. This may alter surgi­cal intervention. The benets and risks of phono­surgery need to be discussed with the patient before surgical intervention. Traditionally surgery consists of making a mucosal incision lateral to the
4.3 Blue Laser Therapy ofVocal Fold Cysts
https://t.me/medicina_free
41
lesion and raising a microap that allows dissec­tion of the cyst from its surrounding structures. Minimizing injury to the vocal ligament during dissection is essential. The anterior and posterior poles of the cyst often are tangled in thick connec­tive tissues. These may be severed using cutting lasers or cold steel instruments. The mucosal lin­ing of the vocal fold is preserved, when possible, to reduce trauma to the deep structures of the lam­ina propria during phonation [60–62]. An alterna­tive treatment is marsupialization of the vocal fold cyst by removing part of its wall [63, 64], but recurrence after this technique is a concern.
The reform in laryngeal practice toward ofce-based surgery has broadened the treatment options for patients with vocal fold cysts. Using a diode laser or a photoangiolytic laser, the lesion can be partially excised or marsupialized in an ofce setting [65, 66]. Of course, the same tech­nique can be used in the operating room. After having introduced the laser glass ber through the working channel of the exible endoscope, an incision is made on the most prominent mucosal surface of the lesion using the laser in a contact mode. The mucus within the cyst is aspirated using a suction catheter or drained by pressure using the distal end of the exible endoscope. In 2020, Gao etal. reported the use of KTP laser in treating four cases of vocal fold mucus retention cysts. There was a marked reduction in VHI-10 score by 12.5 and a decrease in the size of the lesion in all four cases [65]. Similarly, in 2021, Hamdan etal. reported the successful use of thu­lium laser in the in-ofce treatment of three cases of vocal fold mucus retention cysts. Following marsupialization of the wall of the cysts, the mucus content was suctioned using a small cath­eter that was introduced through the working channel of the exible endoscope. The tip of the endoscope was also used to milk the free edge of the vocal fold at the site of the lesion. On follow­ up there was complete regression of the vocal fold cyst in all three cases with preservation of vocal fold cover malleability [66]. Additional research is needed to determine the efcacy of blue laser treatment of exophytic vocal fold lesions compared with the efcacy of traditional resection. Either technique can be performed in
the ofce or in the operating room, and more evi­dence is needed to conrm or refute the suspected benets of each approach.
4.3.2 Case Presentations
4.3.2.1 Case 1: Right Vocal Fold Mucus Retention Cyst
A 57-year-old male patient presented to the Voice Clinic (ALH) with hoarseness of a few months’ duration. He reported work-related voice overuse and abuse but denied any his­tory of smoking. Medical history was positive for gastroesophageal reflux disease treated with proton-pump inhibitor. The Voice Handicap Index-10 (VHI- 10) score was 37. Perceptual evaluation revealed grade 3 dys­phonia with a score of 2 for breathiness, 2 for roughness, and 1 for strain. Acoustic analysis showed a fundamental frequency (F0) of
159.02Hz, habitual pitch (HP) of 149.48Hz,
jitter 1.87, shimmer: 6.33, noise-to-harmonic ratio (NHR): 0.148, voice turbulence index (VTI): 0.066. His maximum phonation time (MPT) was 8.83 s. Laryngeal examination using the flexible nasopharyngoscope showed a mucus retention cyst at the anterior half of the right vocal fold and a reactive lesion on the
Fig. 4.28 Endoscopic view of the larynx showing a mucus retention cyst at the free edge of the right vocal fold. Note the reactive lesion on the contralateral vocal fold
42
https://t.me/medicina_free
4 Blue Laser Therapy ofExudative Lesions oftheVocal Folds
left vocal fold (Fig.4.28). The patient under­went blue laser therapy for his lesion under local anesthesia using the 400nm glass fiber in contact mode. The wall of the cyst was opened using the tip of the glass fiber and the mucus content was suctioned and milked from the cyst by pressure using the distal end of the endoscope (Fig.4.29, Video 4.11). Laryngeal examination 3 weeks after the surgery showed complete regression of the cyst with only mild residual edema and redness at the site of the
Fig. 4.29 Endoscopic view showing the glass ber in contact with the surface of the vocal fold cyst, opening the wall of the cyst (see Video 4.11)
surgery (Fig. 4.30). Laryngeal videostrobo­scopic examination revealed complete closure of the vocal folds during phonation with improvement in the mucosal waves (Video
4.12). The patient had a drop in his VHI-10
score to 2 and a decrease in jitter to 0.70 and in shimmer to 1.67. His voice quality on percep­tual evaluation was almost normal.
4.3.2.2 Case 2: Right Sub-cordal Mass
A 48-year-old male singer with a history of LPR presented with dysphonia despite having had extensive voice therapy. He had multiple laryn­geal procedures, including left vocal fold cyst removal, right vocal fold mass resection, laryn­gocele excision, and a series of 3 of 5 uoroura­cil injection. His laryngeal examination demonstrated bilateral right larger than left sub­cordal mass as well as anterior web. In operat­ing room, the pathology was conrmed visually (Fig. 4.31). The anterior web was vaporized with blue laser in contact and non-contact mode at 6 W, 40ms pulsed, 300 ms pulse duration (Fig. 4.32). Blue laser was used to vaporize right sub-cordal mass. The right sub-cordal mass was not disturbed during this procedure, but staged surgery for the left had been dis­cussed (Fig.4.33). A total 240J were used dur­ing the procedure.
Fig. 4.30 Follow-up view of the larynx 3weeks after the surgery showing complete regression of the right vocal fold cyst with residual edema. (Video 4.12 Laryngeal vid­eostroboscopic examination showing complete regression of the lesion with good closure of the vocal folds during phonation) (▶ https://doi.org/10.1007/000- an7)
Fig. 4.31 Intraoperative microscopic view showing bilateral right larger than left sub-cordal mass. (Video
4.13 Intraoperative video showing right sub-cordal mass
vaporizing using blue laser) (▶ https://doi.org/10.1007/000- an8)
4.3 Blue Laser Therapy of Vocal Fold Cysts
https://t.me/medicina_free
43
Fig. 4.32 Intraoperative microscopic view showing ante­rior web vaporization using blue laser. (Video 4.14 Surgical video showing submucosal treatment of left vocal fold brotic mass using blue laser in contact and non-contact modes) (▶ https://doi.org/10.1007/000- an9)
Fig. 4.33 Intra-operative microscopic view showing vaporization of the right anterior sub-cordal mass by blue laser
The area of resection was injected with a mix­ture of 5 Fluorouracil with triamcinolone. See below for nal surgical view (Fig. 4.34, Video
4.13). His exam motion 6months after surgery demonstrated improvement with his vocal fold vibration and no sub-cordal mass recurrence (Fig.4.35).
Fig. 4.34 Intraoperative microscopic view showing com­plete right sub-cordal mass vaporizing
Fig. 4.35 Laryngeal examination showing no sub-cordal mass recurrence 6months after the laser treatment
4.3.2.3 Case 3: Left Vocal Fold FibroticMass
An 18-year-old woman presented with a history of stable LPR, dysphonia, glottic insufciency, and bilateral vocal fold masses with scar. She had reached maximal improvement with voice therapy and superb reux control. She was taken to the operating room for microdirect laryngoscopy with submucosal treatment of
44
https://t.me/medicina_free
4 Blue Laser Therapy ofExudative Lesions oftheVocal Folds
brotic mass with blue laser. Blue laser treat­ment focused on the left vocal fold as intraop­erative palpation conrmed the left mass and scar to be rm (Figs.4.36, 4.37, 4.38 and Video
4.14). A total 34.4J were used during the pro­cedure. Regression of the rm, brotic left vocal fold lesion, and preservation of the vibra­tory margin mucosa were seen 6months after surgery (Fig.4.39).
Fig. 4.38 Intraoperative, post-treatment, still image showing regression of left vocal fold brotic mass with preservation of vibratory margin mucosa. Soft pliability had been restored
Fig. 4.36 Intraoperative, pre-treatment still image. Note the left true vocal fold brotic mass
Fig. 4.37 Intraoperative, mid-treatment still image of submucosal blue laser treatment of left vocal fold brotic mass. The blue laser was set at 6W, 40ms pulse duration, 300ms pulse pause
Fig. 4.39 Videostroboscopic still image 6months after surgery showing regression of the rm, brotic left vocal fold lesion and preservation of the vibratory margin mucosa
4.4 Surgical Steps inOce­Based Blue Laser Therapy ofExudative Lesions oftheVocal Folds
Step 1: The patient is seated in the upright posi-
tion in a standard examination chair com­monly used in otolaryngology practice. A pad
References
https://t.me/medicina_free
45
behind his or her head may be placed to stabi­lize the head during the procedure.
Step 2: Topical anesthesia to the larynx and phar-
ynx is applied using the transnasal, transoral, or percutaneous cervical approach.
Step 3: A exible laryngoscope with a working
channel and a side-port suction is introduced through the nasal cavity to perform indirect laryngoscopy.
Step 4: The laser glass ber is introduced through
the working channel until the tip of the ber is seen at the end of the endoscope. Note that the introduction of the glass ber is done while the scope is not exed to avoid injury to the working channel. The glass ber can be introduced when the exible endoscope is either in the nasal cavity or before inserting the endoscope into the nose.
Step 5: The exible endoscope with the glass
ber is introduced through the nasopharynx, oropharynx, and hypopharynx until the tar­geted lesion is observed.
Step 6: The glass ber is pushed further distally
and directed toward the lesion.
Step 7: The laser is used in the non-contact mode,
near-contact, or contact mode depending on the type of pathology. In case of vocal fold polyps, the laser is used in a non-contact mode to induce blanching of the lesion, particularly when it is hemorrhagic. In case of Reinke’s edema, the authors (ALH) and (RTS) use the non-contact mode to treat the submucosal microvasculature on the superior surface of the lesion, and then the contact mode and interstitial mode to vaporize the gelatinous substance within the Reinke’s space. The tip of the glass ber is kept inside the submucosal space for 2–3s, but the time varies with the size of the lesion. For a vocal fold mucus retention cyst, the tip of the glass ber is used to incise the wall of the cyst after having treated the lesion in a non-contact mode at the start of the procedure.
Step 8: Steroid injection such as 0.1–0.2mL of
dexamethasone 10 mg/mL may be adminis­tered at the surgical bed toward the end of the surgery. The efcacy of steroid injection remains unproven, but it is used commonly for
surgery in the operating room and in the ofce, and it does not appear to cause adverse effects.
References
1. Klein AM, Lehmann M, Hapner ER, Johns MM III.Spontaneous resolution of hemorrhagic polyps of the true vocal fold. J Voice. 2009;23(1):132–5.
2. Franco RA, Andrus JG.Common diagnoses and treat­ments in professional voice users. Otolaryngol Clin N Am. 2007;40(5):1025–61.
3. Sataloff RT. Structural abnormalities of the larynx. In: Sataloff RT, editor. Professional voice: the science and art of clinical care. 4th ed. San Diego, CA: Plural Publications; 2017. p.1533–86.
4. Vasconcelos DD, Gomes AD, Araújo CM.Vocal fold polyps: literature review. Int Arch Otorhinolaryngol. 2019;23:116–24.
5. Johns MM. Update on the etiology, diagnosis, and treatment of vocal fold nodules, polyps, and cysts. Curr Opin Otolaryngol Head Neck Surg. 2003;11(6):456–61.
6. Jiang C, Jin F.Reux symptom index, reux nding score, esophageal motility and their correlation with laryngopharyngeal reux in patients with vocal cord polyps. Chin J Prim Med Pharm. 2021:886–90.
7. Meng L, Zhang Q, Meng J, Liu Y, Wang D.Correlation between detection results of pepsin in vocal fold polyp tissues and the postoperative efcacy. J Voice. 2022;S0892-1997(22):00064–9. https://doi.
org/10.1016/j.jvoice.2022.02.025.
8. Sakae FA, Sasaki F, Sennes LU, Tsuji DH, Imamura R. Vocal fold polyps and cover minimum struc­tural alterations: associated injuries? Rev Bras Otorrinolaringol. 2004;70:739–41.
9. Eckley CA, Swensson J, Duprat AD, Donati F, Costa HO.Incidence of structural vocal fold abnor­malities associated with vocal fold polyps. Rev Bras Otorrinolaringol. 2008;74:508–11.
10. Smith LJ, Sataloff RT.Bilateral vocal fold polyps. Ear Nose Throat J. 2006;85(8):478.
11. Altman KW.Vocal fold masses. Otolaryngol Clin N Am. 2007;40(5):1091–108.
12. Cielo CA, Finger LS, Rosa JD, Brancalioni AR. Organic and functional lesions: nodules, polyps, and Reinke’s edema. Revista CEFAC. 2011;13:735–48.
13. Dursun G, Karatayli-Ozgursoy S, Ozgursoy OB, Tezcaner ZC, Coruh I, Kilic MA.Inuence of the macroscopic features of vocal fold polyps on the qual­ity of voice: a retrospective review of 101 cases. Ear Nose Throat J. 2010;89(3):E12.
14. Naunheim MR, Carroll TL.Benign vocal fold lesions: update on nomenclature, cause, diagnosis, and treat­ment. Curr Opin Otolaryngol Head Neck Surg. 2017;25(6):453–8.
46
https://t.me/medicina_free
4 Blue Laser Therapy ofExudative Lesions oftheVocal Folds
15. Ido Filho JM, Carvalho B, Mizoguchi FM, do Amaral Catani GS, de Macedo Filho ED, Malafaia O, etal. Characteristics of polypoid lesions in patients undergoing microsurgery of the larynx. Int Arch Otorhinolaryngol. 2013;17(03):279–84.
16. Zhang Y, Jiang JJ.Chaotic vibrations of a vocal fold model with a unilateral polyp. J Acoust Soc Am. 2004;115(3):1266–9.
17. Yamauchi A, Yokonishi H, Imagawa H, Sakakibara KI, Nito T, Tayama N, et al. Quantication of vocal fold vibration in various laryngeal disor­ders using high- speed digital imaging. J Voice. 2016;30(2):205–14.
18. Courey MS, Scott MA, Shohet JA, Ossoff RH. Immunohistochemical characterization of benign laryngeal lesions. Ann Otol Rhinol Laryngol. 1996;105(7):525–31.
19. Weed DT, Courey MS, Ossoff RH.Microlaryngoscopy in the difcult surgical exposure: a new micro­laryngoscope. Otolaryngol Head Neck Surg. 1994;110(2):247–52.
20. Sataloff RT, Spiegel JR, Heuer RJ, Baroody MM, Emerich KA, Hawkshaw MJ, etal. Laryngeal mini­microap: a new technique and reassessment of the microap saga. J Voice. 1995;9(2):198–204.
21. Srirompotong S, Saeseow P, Vatanasapt P.Small vocal cord polyps: completely resolved with conservative treatment. Southeast Asian J Trop Med Public Health. 2004;35:169–71.
22. Hsu YB, Lan MC, Chang SY. Percutaneous cor­ticosteroid injection for vocal fold polyp. Arch Otolaryngol Head Neck Surg. 2009;135(8):776–80.
23. Wang CT, Liao LJ, Cheng PW, Lo WC, Lai MS. Intralesional steroid injection for benign vocal fold disorders: a systematic review and meta-analysis. Laryngoscope. 2013;123(1):197–203.
24. Mouadeb DA, Belafsky PC. In-ofce laryngeal surgery with the 585nm pulsed dye laser (PDL). Otolaryngol Head Neck Surg. 2007;137(3):477–81.
25. Ivey CM, Woo P, Altman KW, Shapshay SM.Ofce pulsed dye laser treatment for benign laryngeal vas­cular polyps: a preliminary study. Ann Otol Rhinol Laryngol. 2008;117(5):353–8.
26. Hamdan AL, Sataloff RT, Hawkshaw MJ. Ofce­based laryngeal laser therapy. In: Ofce-based laryn­geal Surgery. Cham: Springer; 2022. p.213–26.
27. Kim HT, Auo HJ. Ofce-based 585 nm pulsed dye laser treatment for vocal polyps. Acta Otolaryngol. 2008;128(9):1043–7.
28. Del Signore AG, Shah RN, Gupta N, Altman KW, Woo P. Complications and failures of ofce-based endoscopic angiolytic laser surgery treatment. J Voice. 2016;30(6):744–50.
29. Hamdan AL, Khalifee E, Ghanem A.Application of thulium laser as ofce-based procedure in patients with vocal fold polyps. J Voice. 2020;34(1):140–4.
30. Ma J, Fang R, Zhen R, Mao W, Wu X, He P, et al. A 532-nm KTP laser for vocal fold polyps: efcacy and relative factors. Ear Nose Throat J. 2021;100(1 Suppl):87S–93S.
31. Hamdan AL, Ghanem A. Un-sedated ofce-based application of blue laser in vocal fold lesions. J Voice.
2021. https://doi.org/10.1016/j.jvoice.2021.03.031.
32. Miller BJ, Abdelhamid A, Karagama Y.Applications of ofce-based 445nm blue laser transnasal exible laser surgery: a case series and review of practice. Ear Nose Throat J. 2021;100(1 Suppl):105S–12S.
33. Marcotullio D, Magliulo G, Pezone T. Reinke’s edema and risk factors: clinical and histopathologic aspects. Am J Otolaryngol. 2002;23(2):81–4.
34. Powell J, Cocks HC.Mucosal changes in laryngo­pharyngeal reux—prevalence, sensitivity, specicity and assessment. Laryngoscope. 2013;123(4):985–91.
35. Chung JH, Tae K, Lee YS, Jeong JH, Cho SH, Kim KR, et al. The signicance of laryngopharyngeal reux in benign vocal mucosal lesions. Otolaryngol Head Neck Surg. 2009;141(3):369–73.
36. Titze IR. Mechanical stress in phonation. J Voice. 1994;8(2):99–105.
37. Hamdan AL, Khalifee E, Abi Akl PR, Ghanem A, El Hage A. Pathogenic role of Reinke’s edema in snoring and obstructive sleep apnea. J Voice. 2020;34(3):456–9.
38. Colizza A, Ralli M, Cavalcanti L, Cambria F, Greco A, de Vincentiis M.Voice quality analysis of Reinke’s edema according to recent new classication. J Voice.
2022.
39. Yonekawa H. A clinical study of Reinke’s edema. Auris Nasus Larynx. 1988;15(1):57–78.
40. Tan M, Bryson PC, Pitts C, Woo P, Benninger M.Clinical grading of Reinke’s edema. Laryngoscope. 2017;127(10):2310–3.
41. de Vincentiis M, Ralli M, Cialente F, Greco A, Marcotullio D, Minni A, et al. Reinke’s edema: a proposal for a classication based on morpho­logical characteristics. Eur Arch Otorhinolaryngol. 2020;277(8):2279–83.
42. Sakae FA, Imamura R, Sennes LU, Mauad T, Saldiva PH, Tsuji DH. Disarrangement of col­lagen bers in Reinke’s edema. Laryngoscope. 2008;118(8):1500–3.
43. Díaz-Flores L, Gutiérrez R, del Pino García M, Álvarez-Argüelles H, Díaz-Flores L Jr, López­Campos D. CD34-positive broblasts in Reinke’s edema. Laryngoscope. 2014;124(3):E73–80.
44. Ura-Sabat K, Morawska J, Domka W, Gamrot-Wrzoł M, Scierski W, Niebudek-Bogusz E.The assessment of phonatory and ventilatory functions in patients after microsurgery for Reinke’s edema. Adv Clin Exp Med. 2020;29(7):865–71.
45. Hirano S, Yamashita M, Kitamura M, Takagita SI. Photocoagulation of microvascular and hemor­rhagic lesions of the vocal fold with the KTP laser. Ann Otol Rhinol Laryngol. 2006;115(4):253–9.
46. Courey MS, Stone RE, Gardner GM, Ossoff RH. Endoscopic vocal fold microap: a three­year experience. Ann Otol Rhinol Laryngol. 1995;104(4):267–73.
47. Remacle M, Lawson G, Watelet JB.Carbon dioxide laser microsurgery of benign vocal fold lesions: indi-
References
https://t.me/medicina_free
47
cations, techniques, and results in 251 patients. Ann Otol Rhinol Laryngol. 1999;108(2):156–64.
48. Tateya I, Omori K, Kojima H, Hirano S, Kaneko K, Ito J.Steroid injection for Reinke’s edema using beroptic laryngeal surgery. Acta Otolaryngol. 2003;123(3):417–20.
49. Woo P.Hyaluronidase injection in the vocal folds for vocal hemorrhage, Reinke edema, and hyaluronic acid overinjection: a novel application in the larynx. J Voice. 2018;32(4):492–8.
50. Zeitels SM, Burns JA, Akst LM, Hillman RE, Broadhurst MS, Anderson RR. Ofce-based and microlaryngeal applications of a ber­based thulium laser. Ann Otol Rhinol Laryngol. 2006;115(12):891–6.
51. Pitman MJ, Lebowitz-Cooper A, Iacob C, Tan M. Effect of the 532nm pulsed KTP laser in the treatment of Reinke’s edema. Laryngoscope. 2012;122(12):2786–92.
52. Koszewski IJ, Hoffman MR, Young WG, Lai YT, Dailey SH.Ofce-based photoangiolytic laser treat­ment of Reinke’s edema: safety and voice outcomes. Otolaryngol Head Neck Surg. 2015;152(6):1075–81.
53. Hamdan AL, Ghanem A, Abi Akl PR, El Hage A. Unsedated ofce-based thulium laser ther­apy in patients with Reinke’s edema. J Voice. 2022;36(1):134–9.
54. Ghanem A, Hamdan AL.Unsedated ofce-based blue laser therapy in female patients with Reinke’s edema: a retrospective review of 8 cases. J Voice. 2022.
https://doi.org/10.1016/j.jvoice.2022.08.025.
55. Abitbol J, Abitbol P, Abitbol B.Sex hormones and the female voice. J Voice. 1999;13(3):424–46.
56. Echternach M, Burk F, Burdumy M, Herbst CT, Köberlein M, Döllinger M, et al. The inu­ence of vocal fold mass lesions on the passag­gio region of professional singers. Laryngoscope. 2017;127(6):1392–401.
57. Rosen CA, Lombard LE, Murry T. Acoustic, aero­dynamic, and videostroboscopic features of bilat­eral vocal fold lesions. Ann Otol Rhinol Laryngol. 2000;109(9):823–8.
58. Rubin JS, Yanagisawa E.Benign vocal fold pathol­ogy through the eyes of the laryngologist. In: Rubin JS, Sataloff RT, Korovin GS, editors. Diagnosis and treatment of voice disorders. San Diego, CA: Plural Publishing; 2014. p.95–115.
59. Shohet JA, Courey MS, Scott MA, Ossoff RH.Value of videostroboscopic parameters in differentiating true vocal fold cysts from polyps. Laryngoscope. 1996;106(1):19–26.
60. Sataloff RT, Hawkshaw MJ, Sataloff JB, etal. Atlas of laryngoscopy. San Diego, CA: Plural Publishing;
2012.
61. Sataloff RT. Voice surgery. In: Sataloff RT, editor. Professional voice: the science and art of clinical care. 4th ed. San Diego, CA: Plural Publishing; 2017. p.1371–478.
62. Zeitels SM. Phonomicrosurgical techniques. In: Sataloff RT, editor. Professional voice: the science and art of clinical care. 4th ed. San Diego, CA: Plural Publishing; 2017. p.1479–500.
63. Chang HP, Chang SY. An alternative surgical pro­cedure for the treatment of vocal fold retention cyst. Otolaryngol Head Neck Surg. 2003;128(4):470–7.
64. Hsu CM, Armas GL, Su CY. Marsupialization of vocal fold retention cysts: voice assessment and surgical outcomes. Ann Otol Rhinol Laryngol. 2009;118(4):270–5.
65. Gao WZ, Abu-Ghanem S, Reder LS, Amin M, Johns MM.A novel approach to vocal fold mucous retention cysts: awake KTP laser-assisted marsupialization. J Voice. 2022;36(4):570–3.
66. Hamdan AL, Rizk SA.Unsedated ofce-based thu­lium laser therapy in patients with vocal fold cysts. Ear Nose Throat J. 2021;100(1):NP39–42.
Blue Laser Therapy ofVocal
https://t.me/medicina_free
Process Granuloma
5
5.1 Introduction
Vocal process granuloma is a non-neoplastic lesion of the posterior glottis. It was rst described by Chevalier Jackson in 1928 as a contact ulcer of the vocal process. Since then, several syn­onyms have been used to denote the same pathol­ogy among which is pyogenic granuloma, peptic granuloma, inammatory polyps, intubation granuloma, and contact ulcer [1–6]. On histo­logic examination, vocal process granuloma is not a true granulomatous lesion and lacks mono­nuclear and multinuclear histiocytes commonly seen in a granulomatous process. The lesion con­sists of granulation tissue and brosis covered by an intact or ulcerated epithelium. In a histo­morphological analysis of 149 laryngeal granu­loma, Luzar etal. reported epithelial hyperplasia, atrophic epithelium, and abnormal hyperplasia in
65.8%, 16.1%, and 4.7% of the cases, respec­tively [7]. Notably, there was no atypical hyper­plasia or carcinoma in any of the cases.
Vocal process granuloma is more common in men than in women with a high prevalence in the fourth and fth decades of life. Children can be
affected at any age, particularly following a trau­matic laryngeal manipulation [8]. The etiology of vocal process granuloma is multifaceted. The most common causes are mechanical injury to the mucosal lining, gastroesophageal/laryngo­pharyngeal reux, and phonotrauma. It is esti­mated that 30–50% of patients with vocal process granuloma have a history of laryngeal manipula­tion such as difcult or prolonged intubation [5,
6, 9]. It is also well established that a large per-
centage of patients with vocal process granuloma report symptoms of heartburn and regurgitation suggestive of reux disease and esophageal dys­function [10, 11]. Both acidic and non-acidic gas­troduodenal contents can injure the defenseless mucosal lining of the larynx resulting in ulcer­ation and mass proliferation. The insult to the mucosal lining triggers an inammatory cascade that leads to proliferation of capillaries with col­lagen formation and non-specic remodeling of the underlying cartilage often referred to as osteosclerosis [3, 12]. Another etiologic factor of vocal process granuloma is phonotrauma. Hard glottal attack, persistent cough, and excess vocal loading may precipitate injury to the mucosal lin-
Supplementary Information The online version con­tains supplementary material available at https://doi.
org/10.1007/978- 3- 031- 35283- 6_5. The videos can be
accessed individually by clicking the DOI link in the accompanying gure caption or by scanning this link with the SN More Media App.
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 A.-L. Hamdan et al., Blue Laser Surgery in Laryngology,
https://doi.org/10.1007/978-3-031-35283-6_5
49
50
https://t.me/medicina_free
5 Blue Laser Therapy ofVocal Process Granuloma
ing of the vocal process and lead to inammation with mass formation. This is not surprising given the high prevalence of hard glottal attack in patients with structural and functional voice dis­orders [13]. In a review of 41 cases of vocal pro­cess granuloma, Shoffel-Havakuk etal. reported vocal abuse and psychological stress in 41% and 37% of the cases, respectively [11].
The clinical presentation of patients with vocal process granuloma varies with more than 2/3 of affected patients being asymptomatic [11]. The most reported symptoms are repetitive throat clearing, globus sensation, foreign body sensation, cough, dysphagia, and odynophagia. A change in voice quality is an infrequent symp­tom and when present the voice is perceived as low pitch voice and at times breathy [14]. In cases of a large obstructive lesion, patients may also present with dyspnea and stridor. The diag­nosis of vocal process granuloma is based on laryngeal examination. The lesion can be unilat­eral or bilateral, sessile or pedunculated with or without ulceration. In iatrogenic cases, the lesion is more likely to be pedunculated in com­parison to spontaneous vocal process granulo­mas. Note that signs of reux can be observed on laryngeal examination in almost 29% of the cases [11]. Several grading systems for vocal process granuloma have been suggested based on the surface appearance of the lesion and its extension [15]. The predictive value of these classications in regard to treatment is not well established.
Different treatment strategies for vocal pro­cess granuloma have been described. These include behavioral modications, surgical exci­sion using cold steel instruments or lasers, intral­esional steroid injections, and the use of botulinum toxin injections. Karkos et al. con­ducted a systematic review on the management strategies of vocal process granuloma and showed that conservative treatment is the rst approach adopted by otolaryngologists [16]. Conservative therapy consists primarily of behavior modica­tion such as improvement in vocal hygiene and phonatory habits, in addition to the treatment of co-existing diseases such as laryngopharyngeal reux. Ylitalo and Hammarberg investigated the
impact of voice therapy in 19 patients with vocal process granulomas and reported a signicant decrease in vocal fry and hyperfunction [14]. The voice rehabilitation program consisted of breath­ing and relaxation exercises, in addition to cor­rection of laryngeal hyperfunctional behavior using the “the accent method” described by Smith and Thyme in 1978 [17]. In patients who fail conservative therapy, surgical excision is usu­ally offered. Traditionally, surgery is performed in the operating room under general anesthesia. More than one surgical intervention is often needed and the recurrence rate is high [18, 19]. The use of lasers has been advocated by some to reduce the recurrence rate. In 2008, Lin et al. reported the successful use of potassium titanyl phosphate (KTP) laser in the operating room in 12 cases of intubation vocal process granuloma. All patients had regression of the lesion after more than one year follow-up, with marked improvement in their voice perceptual evaluation [20].
With the introduction of the exible endo­scope with a working channel, ofce-based laser therapy has gained popularity as a safe and alter­native treatment of vocal process granuloma. Different types of lasers delivered via glass bers have been used with main preference for photoangiolytic lasers given their high afnity to oxyhemoglobin. In 2006, Rees et al. reported their experience with the pulse dye laser (PDL) in the management of 131 patients including 18 with vocal process granuloma. The authors noted that in-ofce therapy was the preferred treatment method in 87% of the patients [21]. That same year, Zeitels etal. described the successful use of thulium laser in 2 cases of vocal process granu­loma [22]. In 2007, Koufman etal. reported a success rate of 68% in a cohort of 33 patients treated using different types of lasers [23]. Mouadeb and Belafsky also reported the use of ofce-based PDL in the treatment of 47 patients, 8 of whom had vocal process granuloma. Two­thirds of their study group were successfully treated and only one-third required surgical intervention in the operating room [24]. In 2014, Mascarella and Young reported the combined use of KTP laser and cup forceps in-ofce in a